Skip to content

The effect of Transcutaneous Electrical Nerve (TENS) on the restless leg syndrome (RLS)

The effect of Transcutaneous Electrical Nerve (TENS) on the restless leg syndrome (RLS) In patients with this complaint

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191217045764N2
Enrollment
30
Registered
2021-02-01
Start date
2020-02-24
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless Legs Syndrome. Restless legs syndrome

Interventions

Intervention 1: Intervention group: In this study, the transcutaneous electrical nerve stimulation (TENS) electric current is used at a frequency of 100 Hz, three times in three consecutive days, for

Sponsors

Esfarayen University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to No maximum

Inclusion criteria

Inclusion criteria: People over 35 years old Restless leg syndrome based on patient self-report Restless leg syndrome based on a doctor's diagnosis in the final step, score higher than 4 based on the standard questionnaire

Exclusion criteria

Exclusion criteria: History of neurological disease other than Restless Legs Syndrome Presence of vascular diseases other than restless legs syndrome according to the doctor's opinion Neuromuscular Disorders (Technique Problem) Experience the crisis over the past 3 months Patient's unwillingness to cooperate in design Severe stress to the individual or family over the past two weeks (death of a family member, ...) Intensification of RLS Use of antispasmodics over the past two weeks Use of anticonvulsants in the past two weeks Use of antidepressants over the past two weeks Use of sedatives over the past two weeks Using herbal remedies or any non-pharmacological treatments for treating restless legs syndrome over the past two weeks

Design outcomes

Primary

MeasureTime frame
Severity of restless leg syndrome. Timepoint: Before the start of the first stage intervention, before the start of the second stage intervention, before the start of the third stage intervention, the day after the third stage intervention. Method of measurement: Using the International Restless Legs Syndrome Study Group (IRLSS) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Abedi

Esfarayen University of Medical Sciences

mtadayonfar@yahoo.com05144011300-6

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026